Literature DB >> 2614474

"Grumose degeneration" of Trétiakoff.

N Arai1, S Yagishita, N Amano, K Iwabuchi, K Misugi.   

Abstract

We reviewed Trétiakoff's "grumose degeneration (GD)" which described pathologic cellular change in the substantia nigra (SN). This term has been occasionally used up to the mid-1960s by Greenfield et al.; it has rarely been used after the 1970s. This study emphasises the following: (1) after the 1970s, GD has sometimes been signalled in the SN under various names, such as "spheroid with foamy appearance", "granular spheroid", "saccular structure", or "foamy spheroid body"; (2) the ultrastructure of GD is unknown, being entirely different from that of typical axonal swellings (so-called "spheroids"); (3) more attention should be paid to GD in the SN because its nature has remained unclarified since the original description; and (4) "GD" in the cerebellar dentate nucleus is essentially different from Trétiakoff's GD.

Entities:  

Mesh:

Year:  1989        PMID: 2614474     DOI: 10.1016/0022-510x(89)90240-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Peculiar axonal debris with subsequent astrocytic response (foamy spheroid body). A topographic, light microscopic, immunohistochemical and electron microscopic study.

Authors:  N Arai; S Yagishita; K Misugi; M Oda; K Kosaka; T Mizutani; Y Morimatsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Foamy spheroid bodies in the globus pallidus and the substantia nigra pars reticulata: an investigation on regional distribution in 56 cases without neurodegenerative diseases.

Authors:  N Arai; T Mizutani; Y Morimatsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Cytoplasmic inclusions of astrocytic elements of glial tumors: special reference to round granulated body and eosinophilic hyaline droplets.

Authors:  T Hitotsumatsu; T Iwaki; M Fukui; J Tateishi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.